ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Novo Nordisk A/s Complete list of announcements declared & dividend announcements by Novo Nordisk A/s NVO

Novo Nordisk A/s NVO listed on NYSE and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Novo Nordisk A/s NVO

Looking for a Growth Stock? 3 Reasons Why Novo Nordisk (NVO) is a Solid Choice
Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a growth stock that can live up to its true potential can be a toug
Announcement as on 04 July 2022

Novo Nordisk's Ozempic drug gets FDA OK for 2 mg dose to treat Type-2 Diabetes
Novo Nordisk's Ozempic drug gets FDA OK for 2 mg dose to treat Type-2 Diabetes
Announcement as on 29 March 2022

Novo Nordisk launches anti-diabetes pill semaglutide in India
Novo Nordisk, the Danish drug maker on Thursday announced the launch of oral semaglutide in India for treatment of type 2 diabetes.
Announcement as on 20 January 2022

Novo Nordisk strikes .3 billion deal to buy research partner Dicerna Pharmaceuticals
Novo Nordisk said it's buying Dicerna Pharmaceuticals for .3 billion, or .25 per share in cash. Dicerna ended Wednesday at .28. Novo Nordisk already had a research collaboration with Dicerna, and said the deal is part of a strategy of using a bro
Announcement as on 18 November 2021

Prothena sells amyloidosis portfolio to Novo Nordisk for up to .2 billion
Shares of Prothena Corp. Plc were up 1.3% in premarket trading on Monday after the company announced a deal to sell its ATTR amyloidosis portfolio to Novo Nordisk in a 0 million deal that is worth up to .2 billion, based on milestones. ATTR amyloidos
Announcement as on 12 July 2021

Announcements by Novo Nordisk A/s first page | Next page | Prev page |

NVO Novo Nordisk A/s current price & indicator signals

Moving Averages for Novo Nordisk A/s

  • 5Day Average: 39.02
  • 12Day Average: 38.68
  • 20Day Average: 38.39
  • 50Day Average: 42.06
  • 100Day Average: 44.63
  • 150Day Average: 43.6
  • 200Day Average: 44.74

NVO Indicators & signals

Indicator MACD (12,26,9)

38.87, 39.61, -1.16
Indicator MACD is in negative zone

Indicator ADX (14)

2.22, 23.4, 24.47
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 53
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NVO Novo Nordisk A/s are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Thu Oct 2026 39.45 38.99 to 39.77 0.97% 0.69 times
21 Wed Oct 2026 39.07 39.05 to 39.49 -0.71% 0.56 times
20 Tue Oct 2026 39.35 38.44 to 39.38 2.45% 0.78 times
19 Mon Oct 2026 38.41 38.35 to 39.15 -1.08% 0.62 times
16 Fri Oct 2026 38.83 38.67 to 39.40 -0.99% 1.17 times
15 Thu Oct 2026 39.22 38.89 to 39.68 2.89% 1.6 times
14 Wed Oct 2026 38.12 37.90 to 38.42 0.16% 1.01 times
13 Tue Oct 2026 38.06 37.98 to 38.89 -1.35% 1 times
12 Mon Oct 2026 38.58 38.26 to 38.85 -0.16% 0.94 times
09 Fri Oct 2026 38.64 38.06 to 38.68 1.2% 1.04 times
08 Thu Oct 2026 38.18 37.51 to 38.23 -0.21% 1.28 times
07 Wed Oct 2026 38.26 37.51 to 38.47 1.95% 1.48 times

Videos related to: NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NVO announcements Novo Nordisk A/s announcements and dividends declared NYSE

 

Back to top